UBS AM’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $246K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $177K | Hold |
|
|||||
|
2023
Q1 | $177K | Buy |
|
|||||
|
2022
Q4 | $447K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $403K | Hold |
|
|||||
|
2021
Q2 | $708K | Buy |
|
|||||
|
2021
Q1 | $764K | Buy |
|
|||||
|
2020
Q4 | $598K | Hold |
|
|||||
|
2020
Q3 | $855K | Sell |
|
|||||
|
2020
Q2 | $1.19M | Buy |
|
|||||
|
2020
Q1 | $609K | Sell |
|
|||||
|
2019
Q4 | $1.26M | Buy |
|
|||||
|
2019
Q3 | $773K | Buy |
|
|||||
|
2019
Q2 | $814K | Buy |
|
|||||
|
2019
Q1 | $602K | Buy |
|
|||||
|
2018
Q4 | $639K | Buy |
|
|||||
|
2018
Q3 | $417K | Buy |
|
|||||
|
2018
Q2 | $239K | Sell |
|
|||||
|
2018
Q1 | $4.83M | Buy |
|
|||||
|
2017
Q4 | $4.3M | Buy |
|
|||||
|
2017
Q3 | $2M | Buy |
|
|||||
|
2017
Q2 | $1.81M | Sell |
|
|||||
|
2017
Q1 | $6.61M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $466K | Buy |
|
|||||
|
2015
Q1 | $380K | Buy |
|